A Prospective Cohort for Subjects With Adult Hemophagocytic Lymphohistiocytosis Like Syndrome

Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Observational
SUMMARY

This prospective study enrolls subjects who have clinical and laboratory manifestations related with hemophagocytic lymphohistiocytosis. The purpose of the study is to evaluate clinical and biological features of adult hemophagocytic lymphohistiocytosis. The enrolled subjects into this study will be evaluated according to the HLH (hemophagocytic lymphohistiocytosis)criteria and treated with systemic immunosuppressive therapy or chemotherapy. All subjects will be regularly monitored by physicians participating in this study.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 80
Healthy Volunteers: f
View:

• Subjects should fulfill the following criteria

‣ Subjects should have at least one of the following problems

• Presence of hemophagocytosis in tissue or bone marrow

∙ Presence of at least 3 conditions among 8 conditions of HLH diagnostic criteria

⁃ Age \> 18 years

⁃ Written informed consents

Locations
Other Locations
Republic of Korea
Samsung Medical Center
RECRUITING
Seoul
Contact Information
Primary
Seok Jin Kim, MD, PhD
kstwoh@skku.edu
+82234101766
Backup
Silvia Park, MD, PhD
silvia.park@samsung.com
+82234103459
Time Frame
Start Date: 2017-01-01
Estimated Completion Date: 2026-12-31
Participants
Target number of participants: 81
Treatments
Hemophagocytosis
Subjects should fulfill the following criteria~1. Subjects should have at least one of the following problems~ 1. Presence of hemophagocytosis in tissue or bone marrow~ 2. Presence of at least 3 conditions among 8 conditions of HLH diagnostic criteria~2. Age \> 18 years~3. Written informed consents~Subjects receive steroids and etoposide
Sponsors
Leads: Samsung Medical Center

This content was sourced from clinicaltrials.gov